Can a morning light session boost immunotherapy? small trial aims to find out
NCT ID NCT07661966
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether using bright light therapy for an hour each morning, delivered through an iPad app, is tolerable for people with advanced melanoma or non-small cell lung cancer who are about to start immunotherapy. The idea is that synchronizing the body's internal clock might help the immune therapy work better. Only 12 participants will be enrolled, and the main goal is to see if they can stick with the light therapy routine, not yet to measure cancer outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bright light therapy delivered via Circadian OS iPad application
- What this could lead to
- If this works, it could show that bright light therapy is a tolerable way to help align patients' body clocks, potentially improving how well immunotherapy works.
- What could go wrong
- This is a very small pilot study with only 12 people, focused on whether the therapy is tolerable, not on whether it actually improves cancer outcomes. It may not lead to any clear benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Weill Cornell Medicine
New York, New York, 10021, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new PET tracer light up hidden cancers?
- Can a new immune drug outsmart Hard-to-Treat tumors?
- Can a pill plus immunotherapy and targeted radiation shrink lung tumors before surgery?
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- Which High-Tech camera is better at spotting skin cancer?